查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1685067

胃内水球市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

Intragastric Balloon Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球胃内水球市场价值为 6,850 万美元，预计 2025 年至 2034 年期间的复合年增长率为 14.8%。推动这一增长的因素包括技术进步、人们对肥胖相关健康风险认识的提高以及医疗支持和保险覆盖范围的扩大。全球肥胖症的日益流行，使得越来越多的人寻求非手术减肥方法，从而推动了胃内水球的需求。这些装置旨在帮助患者感觉更饱腹，从而减少食物摄入，为外科手术提供了微创的替代方案。它们的成本相对较低，加上设计和可用性的不断改进，提高了它们的有效性以及对医疗保健提供者和患者的吸引力。

胃内水球市场 - IMG1

随着肥胖率的上升，对有效减肥介入的需求从未如此强烈。传统的减肥方法，包括节食和运动，往往无法带来长期效果，促使人们探索替代解决方案。胃内水球在生活方式改变和外科手术之间架起了一座有效的桥樑，为体重管理提供了一个临时但有效的解决方案。此外，越来越多的医疗专业人士的认可，加上积极的患者体验，正在推动市场成长。随着消费者对自己的选择越来越了解，对非侵入性减肥治疗的偏好不断上升，这使得胃内水球市场有望大幅扩张。随着肥胖率不断上升，新兴经济体越来越多地采用这些设备，这进一步凸显了该市场的长期潜力。正在进行的研究和开发工作旨在增强球囊的耐用性、提高患者的舒适度、延长治疗时间，确保产业持续成长。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 6850 万美元
预测值 2.684 亿美元
复合年增长率 14.8％

市场按产品类型细分，包括单胃内球囊、双胃内球囊和三胃内球囊。 2024年，单一胃内球囊部分创收4,120万美元。这些气球之所以受到青睐是因为它们易于部署，提供了一个简单的插入过程，可减少手术时间和併发症风险。由于其简单性，它们成为患者和医疗保健提供者的首选，特别是因为它们提供了双气囊系统的经济高效的替代方案。随着人们越来越重视可及性，单一胃内水球继续占据市场主导地位，提供经济实惠且高效的减肥解决方案。

市面上的给药方式包括内视镜和药丸形式，其中内视镜方法在 2024 年占据领先地位，占有 74.3% 的份额。该技术涉及使用内视镜将气囊插入胃中，无需切口或缝合。作为一种微创选择，它降低了风险并缩短了恢復时间，对于寻求高效、低风险减肥方法的人来说是一个有吸引力的选择。内视镜球囊置入术的便利性和安全性极大地促进了其被广泛采用，医疗机构越来越多地推荐它作为肥胖患者的主要干预措施。

2024 年，美国胃内水球市场价值为 2,490 万美元，预计到 2034 年将以 14.8% 的复合年增长率成长。美国食品药物管理局 (FDA) 对这些设备的批准，对于增强消费者信心、确保患者和医疗保健提供者认识到其安全性和有效性起到了重要作用。 FDA 的批准在提高采用率方面发挥了至关重要的作用，越来越多的人将这些产品纳入他们的减肥策略中。美国消费者越来越寻求侵入性更小、恢復期更短、併发症更少的治疗方法，这进一步加速了市场的扩张。随着对创新和非手术减肥解决方案的需求不断增长，预计未来几年美国胃内水球市场将实现强劲且持续的成长。

目录

第 1 章：方法论与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业衝击力
    • 成长动力
      • 肥胖盛行率上升
      • 人们对微创手术的偏好日益增加
      • 技术进步
    • 产业陷阱与挑战
      • 副作用和併发症的风险
  • 成长潜力分析
  • 监管格局
  • 技术格局
  • 报销场景
  • 波特的分析
  • PESTEL 分析
  • 差距分析
  • 价值链分析

第四章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 策略仪表板

第五章：市场估计与预测：按产品，2021 — 2034 年

  • 主要趋势
  • 单胃内球囊
  • 双胃内水球
  • 三重胃内水球

第六章：市场估计与预测：按填充材料，2021 年至 2034 年

  • 主要趋势
  • 盐水球囊
  • 充气气球

第七章：市场估计与预测：依政府划分，2021 年至 2034 年

  • 主要趋势
  • 内视镜检查
  • 药丸形式

第 8 章：市场估计与预测：依最终用途，2021 年至 2034 年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 专科诊所
  • 其他最终用户

第 9 章：市场估计与预测：按地区，2021 年至 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第十章：公司简介

  • Allurion
  • Boston Scientific (Apollo Endosurgery)
  • districlass medical
  • endalis
  • HEALTH WARE
  • helioscopie
  • Medicone
  • medispar
  • OBALON
  • ReShape Lifesciences
  • SHENYUN
  • SILIMED
  • SPATZ
简介目录
Product Code: 1173

The Global Intragastric Balloon Market, valued at USD 68.5 million in 2024, is expected to expand at a CAGR of 14.8% from 2025 to 2034. This surge is driven by advancements in technology, increasing awareness of obesity-related health risks, and greater access to medical support and insurance coverage. The growing prevalence of obesity worldwide has led more individuals to seek non-surgical weight-loss solutions, fueling demand for intragastric balloons. These devices, designed to help patients feel fuller and consume less food, offer a minimally invasive alternative to surgical procedures. Their relatively low cost, coupled with continuous improvements in design and usability, has enhanced their effectiveness and appeal among both healthcare providers and patients.

Intragastric Balloon Market - IMG1

With rising obesity rates, the need for effective weight-loss interventions has never been greater. Traditional weight-loss methods, including diet and exercise, often fail to deliver long-term results, prompting individuals to explore alternative solutions. Intragastric balloons provide an effective bridge between lifestyle modifications and surgical procedures, offering a temporary yet impactful solution for weight management. Additionally, growing endorsements from medical professionals, coupled with positive patient experiences, are propelling market growth. As consumers become more informed about their options, the preference for non-invasive weight-loss treatments continues to rise, positioning the intragastric balloon market for significant expansion. The increasing adoption of these devices in emerging economies, where obesity rates are climbing, further underscores the market's long-term potential. Ongoing research and development efforts aim to enhance balloon durability, improve patient comfort, and extend treatment duration, ensuring sustained growth in the industry.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$68.5 Million
Forecast Value$268.4 Million
CAGR14.8%

The market is segmented by product type, with single, dual, and triple intragastric balloons available. In 2024, the single intragastric balloon segment generated USD 41.2 million. These balloons are preferred due to their ease of deployment, offering a straightforward insertion process that reduces both procedure time and complication risks. Their simplicity makes them the top choice for both patients and healthcare providers, particularly as they offer a cost-effective alternative to dual-balloon systems. With an increasing focus on accessibility, single intragastric balloons continue to dominate the market, providing an affordable yet highly effective weight-loss solution.

Administration methods in the market include endoscopic and pill forms, with the endoscopic method leading in 2024, holding a 74.3% share. This technique involves inserting the balloon into the stomach using an endoscope, eliminating the need for incisions or stitches. As a minimally invasive option, it reduces risks and recovery time, making it an attractive choice for individuals seeking efficient and low-risk weight-loss procedures. The convenience and safety profile of endoscopic balloon placement has significantly contributed to its widespread adoption, with healthcare facilities increasingly recommending it as a primary intervention for patients struggling with obesity.

The intragastric balloon market in the United States was valued at USD 24.9 million in 2024 and is projected to grow at a 14.8% CAGR through 2034. The U.S. Food and Drug Administration (FDA) approval of these devices has been instrumental in boosting consumer confidence, ensuring patients and healthcare providers recognize their safety and effectiveness. FDA clearance has played a crucial role in increasing adoption, with more individuals incorporating these products into their weight-loss strategies. American consumers are increasingly seeking less invasive treatments with shorter recovery periods and fewer complications, further accelerating the market's expansion. As the demand for innovative and non-surgical weight-loss solutions grows, the intragastric balloon market in the United States is expected to witness robust and sustained growth over the coming years.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of obesity
      • 3.2.1.2 Growing preference for minimally invasive procedures
      • 3.2.1.3 Technological advancements
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Risk of side effects and complications
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Reimbursement scenario
  • 3.7 Porter’s analysis
  • 3.8 PESTEL analysis
  • 3.9 Gap analysis
  • 3.10 Value chain analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 — 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Single intragastric balloon
  • 5.3 Dual intragastric balloon
  • 5.4 Triple intragastric balloon

Chapter 6 Market Estimates and Forecast, By Filling Material, 2021 — 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Saline-filled balloon
  • 6.3 Gas-filled balloon

Chapter 7 Market Estimates and Forecast, By Administration, 2021 — 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Endoscopy
  • 7.3 Pill form

Chapter 8 Market Estimates and Forecast, By End Use, 2021 — 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Ambulatory surgical centers
  • 8.4 Specialty clinics
  • 8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 — 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Allurion
  • 10.2 Boston Scientific (Apollo Endosurgery)
  • 10.3 districlass medical
  • 10.4 endalis
  • 10.5 HEALTH WARE
  • 10.6 helioscopie
  • 10.7 Medicone
  • 10.8 medispar
  • 10.9 OBALON
  • 10.10 ReShape Lifesciences
  • 10.11 SHENYUN
  • 10.12 SILIMED
  • 10.13 SPATZ